Dermatofibrosarcoma Protuberans: A Partial Response to Imatinib Therapy

Khosrow Mehrany, Neil A. Swanson, Michael C. Heinrich, Roger H. Weenig, Ken K. Lee, Clifton R. White, Theresa Schroeder Devere

Dermatologic Surgery · 2006 · 34 citations · 11 references

Concepts

Abstract

Research funding provided by Novartis. Dr. Heinrich is a consultant and on the speakers bureau for Novartis. Dermatofibrosarcoma pro-tuberans is a rare cutaneous tumor constituting less than 0.1% of all malignancies. The incidence has been estimated to be 0.8 to 5 cases per 1 million people. Der-matofibrosarcoma protuberans is locally destructive. With its tenta-cle-like projections of neoplastic cells beneath clinically normal-ap-pearing skin, it has high recurrence rates after standard wide local excision. Rates of local recurrence in the head and neck are

References

11